Lipids & metabolic liver disease

Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome

Cardiovasc DiabetolPublished Cohort study

Authors' conclusion

Our study highlights the clinical value of TyG-related indices in predicting the survival of the MetS population. TyG-related indices would be the surrogate biomarkers for the follow-up of the MetS population.

Study context

Population
Adults with metabolic syndrome (MetS) (NCEP ATP III definition), National Health and Nutrition Examination Survey (NHANES) 1999–2018; median age 59 years; 5,570 females and 5,164 males
Participants
10,734 adults
Exposure
High vs low levels of triglyceride-glucose (TyG)-related indices
Outcome
All-cause mortality
Methodological detailsNHANES 1999–2018, multivariate Cox regression, restricted cubic splines, sensitivity analyses
  • NHANES 1999–2018
  • Multivariate Cox regression
  • Restricted cubic splines
  • Sensitivity analyses

Main finding

As reported in the abstract

All-cause mortality, high levels of TyG-related indices
  • TyG index: aHR 1.36 (95% CI 1.18-1.56), p < 0.001
  • TyG-WHtR index: aHR 1.29 (95% CI 1.13-1.47), p < 0.001
  • Multivariate Cox regression

Observational data: associations, not effects.

Further findings

Cardiovascular mortality

TyG-WC: aHR 1.45 (95% CI 1.13-1.85), p = 0.004
TyG-WHtR: aHR 1.50 (95% CI 1.17-1.92), p = 0.002

Diabetes mortality

TyG: aHR 4.06 (95% CI 2.81-5.87), p < 0.001
TyG-WC: aHR 2.55 (95% CI 1.82-3.58), p < 0.001
TyG-WHtR: aHR 2.53 (95% CI 1.81-3.54), p < 0.001

Non-linearity with all-cause mortality (restricted cubic splines (RCS))

Non-linear trend, TyG: p for nonlinearity = 0.004
Non-linear trend, TyG-WC: p for nonlinearity = 0.001

Sensitivity analyses

Supported positive correlations between TyG-related indices and mortality

Original publication

Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. Published 24 April 2024. doi:10.1186/s12933-024-02215-0

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.